CLARIFIES REFERENCE TO CORONAVIRUS SCARE)
With the coronavirus scare still uppermost in many people's minds, stocks in the health-care field enjoyed their share Tuesday of adulation, including those in smaller-cap sectors.
Micro-cap stock number one today is Vancouver-based Else Nutrition Holdings, (TSX-Venture:BABY) focusing on developing and marketing a real alternative to dairy-based infant nutrition. The company signed a five-year production Memorandum of Understanding with a leading U.S. based organic baby formula producer. Else and the partner hope to have the deal done by end of the current quarter.
Else will invest about $500,000 U.S. in a dedicated packaging and manufacturing line for its products.
BABY hopped by a nickel, or 7.8%, to 69 cents, on 136,000 shares.
Micro-cap number two, Sugarland, Texas-based Neutra Corp. (OTC:NTRR), trumpeted Tuesday a new round of private equity just after the New Year that the company intends to use in its ongoing campaign to become a vertically integrated producer, manufacturer and distributor of hemp-based CBD health products.
Said the company CEO "This funding round gives us the ability to pursue our strategies and goals, as well as potentially expand our vision for the future. We had a very successful 2019; this private funding will help us towards an equally accomplished 2020."
NTRR gained 33.3% to $0.008, on more than 38 million shares.
Related Stories
